Peter Qinhua Huang,Deborah Helen Slee,Sayee Gajanan Hegde,Chad Daniel Hopkins,Kevin Duane Bunker,Joseph Robert Pinchman,Rakesh Kumar Sit
申请号：
US16866900
公开号：
US20200261428A1
申请日:
2020.05.05
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Compounds of Formula (I) are estrogen receptor alpha modulators, where the variables in Formula (I) are described in the disclosure. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions that are estrogen receptor alpha dependent and/or estrogen receptor alpha mediated, including conditions characterized by excessive cellular proliferation, such as breast cancer.
